News & Press
Neurotech Devices Market to Reach $34.2B by 2033, North America Leads with 34.9% Share
Coherent Market Insights5/22/2026·05/22/26🌐 USA
Summary
The global neurotech devices market is projected to grow significantly, with North America accounting for 34.9% share in 2026. Key drivers include FDA rapid regulatory approvals, NIH funding, and rising adoption of wearable neuro-monitoring devices for epilepsy and sleep disorders.
Why it matters
A $34.2B market projection by 2033 reflects analyst consensus that neurotech devices are entering a sustained growth phase driven by ageing populations, rising neurological disease burden, and improving cost-effectiveness versus pharmaceutical alternatives. North America leads but Asia is the fastest-growing region.
#BCI#Industry#Neurostimulation#USA
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trialAlready a member? Sign in